Cargando…

Seroprevalence of anti-SARS-CoV-2 antibodies and factors associated with infection among adolescent men who have sex with men and transgender women in Salvador, Brazil

BACKGROUND: Brazil was strongly affected by the COVID-19 pandemic and the impact of the pandemic on sexual and gender minorities’ youth remains unknown. This study aimed to estimate the seroprevalence of SARS-CoV-2 antibodies and associated factors among adolescent men who have sex with men (AMSM) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Santos, Carina C., de M. Lima, Fernanda W., Magno, Laio, Soares, Fabiane, Ferraz, Dulce, Grangeiro, Alexandre, Zucchi, Eliana Miura, Préau, Marie, Mabire, Xavier, Matos, Helen R. S. S., Dourado, Inês
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829219/
https://www.ncbi.nlm.nih.gov/pubmed/36624484
http://dx.doi.org/10.1186/s12889-022-14969-x
_version_ 1784867421914398720
author Santos, Carina C.
de M. Lima, Fernanda W.
Magno, Laio
Soares, Fabiane
Ferraz, Dulce
Grangeiro, Alexandre
Zucchi, Eliana Miura
Préau, Marie
Mabire, Xavier
Matos, Helen R. S. S.
Dourado, Inês
author_facet Santos, Carina C.
de M. Lima, Fernanda W.
Magno, Laio
Soares, Fabiane
Ferraz, Dulce
Grangeiro, Alexandre
Zucchi, Eliana Miura
Préau, Marie
Mabire, Xavier
Matos, Helen R. S. S.
Dourado, Inês
author_sort Santos, Carina C.
collection PubMed
description BACKGROUND: Brazil was strongly affected by the COVID-19 pandemic and the impact of the pandemic on sexual and gender minorities’ youth remains unknown. This study aimed to estimate the seroprevalence of SARS-CoV-2 antibodies and associated factors among adolescent men who have sex with men (AMSM) and transgender women (ATGW) participants of a human immunodeficiency virus (HIV) pre-exposure prophylaxis cohort study (PrEP1519). METHODS: This is a cross-sectional design conducted between June and October 2020 in Salvador, Brazil. Serum samples were collected from AMSM and ATGW aged 16-21 years between June-October 2020. IgG and IgM anti-SARS-CoV-2 were detected by chemiluminescence immunoassay, and data were collected through a socio-behavioral questionnaire. RESULTS: Among the 137 participants, the seroprevalence of anti-SARS-CoV-2 IgG and IgM was 20.4%; 16.8% of the participants were positive for IgG, and 11.7% for IgM. In the multivariable analysis, the seroprevalence was two times higher among those who never wore masks (OR= 2.22; 95% CI: 1.08-4.57) and among those who believed that they could be easily cured of the disease (OR= 2.05; 95% CI: 1.05-4.01). CONCLUSIONS: The high seroprevalence of SARS-CoV-2 antibodies among gender and sexual minority youth seems to be informed by behaviors and attitudes that contrast with public health measures and the potential severity of the disease when vaccination was still not available.
format Online
Article
Text
id pubmed-9829219
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-98292192023-01-10 Seroprevalence of anti-SARS-CoV-2 antibodies and factors associated with infection among adolescent men who have sex with men and transgender women in Salvador, Brazil Santos, Carina C. de M. Lima, Fernanda W. Magno, Laio Soares, Fabiane Ferraz, Dulce Grangeiro, Alexandre Zucchi, Eliana Miura Préau, Marie Mabire, Xavier Matos, Helen R. S. S. Dourado, Inês BMC Public Health Research BACKGROUND: Brazil was strongly affected by the COVID-19 pandemic and the impact of the pandemic on sexual and gender minorities’ youth remains unknown. This study aimed to estimate the seroprevalence of SARS-CoV-2 antibodies and associated factors among adolescent men who have sex with men (AMSM) and transgender women (ATGW) participants of a human immunodeficiency virus (HIV) pre-exposure prophylaxis cohort study (PrEP1519). METHODS: This is a cross-sectional design conducted between June and October 2020 in Salvador, Brazil. Serum samples were collected from AMSM and ATGW aged 16-21 years between June-October 2020. IgG and IgM anti-SARS-CoV-2 were detected by chemiluminescence immunoassay, and data were collected through a socio-behavioral questionnaire. RESULTS: Among the 137 participants, the seroprevalence of anti-SARS-CoV-2 IgG and IgM was 20.4%; 16.8% of the participants were positive for IgG, and 11.7% for IgM. In the multivariable analysis, the seroprevalence was two times higher among those who never wore masks (OR= 2.22; 95% CI: 1.08-4.57) and among those who believed that they could be easily cured of the disease (OR= 2.05; 95% CI: 1.05-4.01). CONCLUSIONS: The high seroprevalence of SARS-CoV-2 antibodies among gender and sexual minority youth seems to be informed by behaviors and attitudes that contrast with public health measures and the potential severity of the disease when vaccination was still not available. BioMed Central 2023-01-09 /pmc/articles/PMC9829219/ /pubmed/36624484 http://dx.doi.org/10.1186/s12889-022-14969-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Santos, Carina C.
de M. Lima, Fernanda W.
Magno, Laio
Soares, Fabiane
Ferraz, Dulce
Grangeiro, Alexandre
Zucchi, Eliana Miura
Préau, Marie
Mabire, Xavier
Matos, Helen R. S. S.
Dourado, Inês
Seroprevalence of anti-SARS-CoV-2 antibodies and factors associated with infection among adolescent men who have sex with men and transgender women in Salvador, Brazil
title Seroprevalence of anti-SARS-CoV-2 antibodies and factors associated with infection among adolescent men who have sex with men and transgender women in Salvador, Brazil
title_full Seroprevalence of anti-SARS-CoV-2 antibodies and factors associated with infection among adolescent men who have sex with men and transgender women in Salvador, Brazil
title_fullStr Seroprevalence of anti-SARS-CoV-2 antibodies and factors associated with infection among adolescent men who have sex with men and transgender women in Salvador, Brazil
title_full_unstemmed Seroprevalence of anti-SARS-CoV-2 antibodies and factors associated with infection among adolescent men who have sex with men and transgender women in Salvador, Brazil
title_short Seroprevalence of anti-SARS-CoV-2 antibodies and factors associated with infection among adolescent men who have sex with men and transgender women in Salvador, Brazil
title_sort seroprevalence of anti-sars-cov-2 antibodies and factors associated with infection among adolescent men who have sex with men and transgender women in salvador, brazil
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829219/
https://www.ncbi.nlm.nih.gov/pubmed/36624484
http://dx.doi.org/10.1186/s12889-022-14969-x
work_keys_str_mv AT santoscarinac seroprevalenceofantisarscov2antibodiesandfactorsassociatedwithinfectionamongadolescentmenwhohavesexwithmenandtransgenderwomeninsalvadorbrazil
AT demlimafernandaw seroprevalenceofantisarscov2antibodiesandfactorsassociatedwithinfectionamongadolescentmenwhohavesexwithmenandtransgenderwomeninsalvadorbrazil
AT magnolaio seroprevalenceofantisarscov2antibodiesandfactorsassociatedwithinfectionamongadolescentmenwhohavesexwithmenandtransgenderwomeninsalvadorbrazil
AT soaresfabiane seroprevalenceofantisarscov2antibodiesandfactorsassociatedwithinfectionamongadolescentmenwhohavesexwithmenandtransgenderwomeninsalvadorbrazil
AT ferrazdulce seroprevalenceofantisarscov2antibodiesandfactorsassociatedwithinfectionamongadolescentmenwhohavesexwithmenandtransgenderwomeninsalvadorbrazil
AT grangeiroalexandre seroprevalenceofantisarscov2antibodiesandfactorsassociatedwithinfectionamongadolescentmenwhohavesexwithmenandtransgenderwomeninsalvadorbrazil
AT zucchielianamiura seroprevalenceofantisarscov2antibodiesandfactorsassociatedwithinfectionamongadolescentmenwhohavesexwithmenandtransgenderwomeninsalvadorbrazil
AT preaumarie seroprevalenceofantisarscov2antibodiesandfactorsassociatedwithinfectionamongadolescentmenwhohavesexwithmenandtransgenderwomeninsalvadorbrazil
AT mabirexavier seroprevalenceofantisarscov2antibodiesandfactorsassociatedwithinfectionamongadolescentmenwhohavesexwithmenandtransgenderwomeninsalvadorbrazil
AT matoshelenrss seroprevalenceofantisarscov2antibodiesandfactorsassociatedwithinfectionamongadolescentmenwhohavesexwithmenandtransgenderwomeninsalvadorbrazil
AT douradoines seroprevalenceofantisarscov2antibodiesandfactorsassociatedwithinfectionamongadolescentmenwhohavesexwithmenandtransgenderwomeninsalvadorbrazil
AT seroprevalenceofantisarscov2antibodiesandfactorsassociatedwithinfectionamongadolescentmenwhohavesexwithmenandtransgenderwomeninsalvadorbrazil